RAS-Targeted Drug Discovery Summit 2019 Designing Novel Pan-mut-KRAS Inhibitors

Skip to content

September 24-26, 2024

Boston MA

VIEW 2024 EVENT GUIDE

Home
About
What’s On
Partnership
Take Part
- Pricing & Registration
- Contact Us

Designing Novel Pan-mut-KRAS Inhibitors

Time: 2:45 pm
day: Day One Track A PM

Speakers:

Lynn Kirkpatrick

Lynn Kirkpatrick

VENUE

Revere Hotel Boston Common
200 Stuart Street
Boston, MA 02116

LOCATION

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok